[Prognostic differences among different age limits in Chinese elderly patients with non-Hodgkin's lymphoma].
OBJECTIVE
To explore the feasible age limits in Chinese elderly patients with non-Hodgkin's lymphoma (NHL).


METHODS
The clinical data of 507 patients with NHL who were admitted to Peking Union Medical College Hospital (PUMCH) from January 1990 to December 2007 were retrospectively analyzed. They were further followed up by reviewing medical records or by phone. The deadline of follow-up was October 2008.


RESULTS
The 5-year/8-year overall survival (OS) rates were 64.6%/45.7%, 53.0%/ 44.1%, 32.8%/17.5%, 40.0%/22.8%, and 19.8%/0, respectively, in patients aged < 60 years, 60-64 years, 65-69 years, 70-74 years, and > or = 75 years. The OS rate was significantly different between patients aged > or = 75 years and other age groups, and between patients aged 65-70 years and patients younger than 60 years (P < 0.05). Only age, serum albumin, and hemoglobin affected the survival status in elderly NHL patients.


CONCLUSIONS
Sixty-five years can be regarded as the age limit in Chinese NHL patients.
Xie
Hai-Yan
HY
International Medical Service, PUMC Hospital, CAMS and PUMC, Beijing 100730, China.
Zhou
Dao-Bin
DB
Wang
Shu-Jie
SJ
Han
Bing
B
Zhang
Wei
W
Jiao
Li
L
Li
Jian
J
Wu
Yong-Ji
YJ
Zhao
Yong-Qiang
YQ
Shen
Ti
T
Xu
Tao
T
D000367:Age Factors; D000368:Aged; D000369:Aged, 80 and over; D002681:China / Q000453:epidemiology; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008228:Lymphoma, Non-Hodgkin / Q000401:mortality*; D008297:Male; D008875:Middle Aged; D011379:Prognosis; D012189:Retrospective Studies; D015996:Survival Rate